MCCS publishes ‘broader’ cannabis prescription guidelines

The Medical Cannabis Clinicians’ Society (MCCS) and the All-Party Parliamentary Group (APPG) for Medical Cannabis under Prescription issued new guidance last week identifying conditions for which there are “conclusive or substantial”, “moderate”, and “limited” evidence of efficacy of medical cannabis treatment, as well as those for which it says there is “no conclusive evidence”. Mike […]

Continue Reading

Alzheimer’s Research UK announces ‘cannabis-based’ Sativex trial for dementia

The UK’s leading dementia research charity Alzheimer’s Research UK has announced it will fund a “pioneering” clinical trial at King’s College London using the “cannabis-based” treatment Sativex for people living with dementia. Sativex is a peppermint-flavoured mouth spray that contains a 1:1 ratio of two key cannabinoids found in the cannabis plant – delta-9-tetrahydrocannabinol (THC) […]

Continue Reading